Poniard Pharmaceuticals Inc (OTC Pink - No Information:PARD)

0.0691
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
0.01
Today|||52-Week Range
0.10
+277.80%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$103.6K

Company Description

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of oncology products. The company is currently focusing on developing picoplatin, a new and differentiated platinum-based chemotherapeutic agent that is used in the clinical development for multiple cancer indications, treatment combinations, and by different routes of administration. The company was founded in 1984 and is headquartered in Seattle, WA.

Contact Information

Poniard Pharmaceuticals, Inc.
300 Elliott Avenue West
Seattle Washington 98119
P:(206) 281-7001
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

There are no executives to display.